Paediatric asthma: Everything that seemed to be certain no longer is

Paediatric Respiratory Reviews

Volumn 11, Issue 3, 2010, Pages 185-190

  Boehmer, Annemie L M ^a  

^a Maasstad Hospital Rotterdam   (Netherlands)

Author keywords

Acute viral wheeze; Aetiology; Asthma monitoring; Corticosteroids; Day care; Exhaled NO; Paediatric asthma; Preschool wheeze; Risk factors; Treatment; Virus

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; NITRIC OXIDE; PREDNISOLONE;

ASTHMA; ATOPY; CHILD CARE; CHILD HEALTH; CLINICAL TRIAL; DAY CARE; DISEASE CONTROL; DRUG CONTRAINDICATION; DRUG MEGADOSE; HUMAN; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RHINOVIRUS; RISK ASSESSMENT; RISK FACTOR; VIRAL BRONCHIOLITIS; VIRUS INFECTION; WHEEZING;

ASTHMA; CHILD; HUMANS; NITRIC OXIDE;

EID: 77955421173     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2010.05.002     Document Type: Review

References (37)

1. Brand P.L., Baraldi E., Bisgaard H., Boner A.L., Castro-Rodriguez J.A., Custovic A., et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J. 2008, 32(4):1096-1110.
2. Bacharier L.B., Guilbert T.W., Zeiger R.S., Strunk R.C., Morgan W.J., Lemanske R.F., et al. Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. J Allergy Clin Immunol. 2009, 123(5):1077-1082. 82 e1-5.
3. Martinez F.D. What have we learned from the Tucson Children's Respiratory Study?. Paediatr Respir Rev. 2002, 3(3):193-197.
4. Lemanske R.F., Jackson D.J., Gangnon R.E., Evans M.D., Li Z., Shult P.A., et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 2005, 116(3):571-577.
5. Singh A.M., Moore P.E., Gern J.E., Lemanske R.F., Hartert T.V. Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation. Am J Respir Crit Care Med. 2007, 175(2):108-119.
6. Kusel M.M., de Klerk N.H., Kebadze T., Vohma V., Holt P.G., Johnston S.L., et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007, 119(5):1105-1110.
7. Stein R.T., Sherrill D., Morgan W.J., Holberg C.J., Halonen M., Taussig L.M., et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999, 354(9178):541-545.
8. Sigurs N., Bjarnason R., Sigurbergsson F., Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000, 161(5):1501-1507.
9. Thomsen S.F., van der Sluis S., Stensballe L.G., Posthuma D., Skytthe A., Kyvik K.O., et al. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med. 2009, 179(12):1091-1097.
10. Wu P., Dupont W.D., Griffin M.R., Carroll K.N., Mitchel E.F., Gebretsadik T., et al. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med. 2008, 178(11):1123-1129.
11. Devulapalli C.S., Carlsen K.C., Haland G., Munthe-Kaas M.C., Pettersen M., Mowinckel P., et al. Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age. Thorax. 2008, 63(1):8-13.
12. Jackson D.J., Gangnon R.E., Evans M.D., Roberg K.A., Anderson E.L., Pappas T.E., et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008, 178(7):667-672.
13. Henderson J., Hilliard T.N., Sherriff A., Stalker D., Al Shammari N., Thomas H.M. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol. 2005, 16(5):386-392.
14. Kuehni C.E., Spycher B.D., Silverman M. Causal links between RSV infection and asthma: no clear answers to an old question. Am J Respir Crit Care Med. 2009, 179(12):1079-1080.
15. Sly P.D., Boner A.L., Bjorksten B., Bush A., Custovic A., Eigenmann P.A., et al. Early identification of atopy in the prediction of persistent asthma in children. Lancet. 2008, 372(9643):1100-1106.
16. Caudri D., Wijga A., Scholtens S., Kerkhof M., Gerritsen J., Ruskamp J.M., et al. Early daycare is associated with an increase in airway symptoms in early childhood but is no protection against asthma or atopy at 8 years. Am J Respir Crit Care Med. 2009, 180(6):491-498.
17. Ball T.M., Castro-Rodriguez J.A., Griffith K.A., Holberg C.J., Martinez F.D., Wright A.L. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med. 2000, 343(8):538-543.
18. Celedon J.C., Wright R.J., Litonjua A.A., Sredl D., Ryan L., Weiss S.T., et al. Day care attendance in early life, maternal history of asthma, and asthma at the age of 6 years. Am J Respir Crit Care Med. 2003, 167(9):1239-1243.
19. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007; 120(5 Suppl):S94-138.
20. British Guideline on the Management of Asthma. Thorax. 2008; 63 Suppl 4:iv1-121.
21. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008 accessed online March 2010; 31(1):143-178.
22. Davies G., Paton J.Y., Beaton S.J., Young D., Lenney W. Children admitted with acute wheeze/asthma during November 1998-2005: a national UK audit. Arch Dis Child. 2008, 93(11):952-958.
23. Csonka P., Kaila M., Laippala P., Iso-Mustajarvi M., Vesikari T., Ashorn P. Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial. J Pediatr. 2003, 143(6):725-730.
24. Oommen A., Lambert P.C., Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet. 2003, 362(9394):1433-1438.
25. Jartti T., Lehtinen P., Vanto T., Vuorinen T., Hartiala J., Hiekkanen H., et al. Efficacy of prednisolone in children hospitalized for recurrent wheezing. Pediatr Allergy Immunol. 2007, 18(4):326-334.
26. Panickar J., Lakhanpaul M., Lambert P.C., Kenia P., Stephenson T., Smyth A., et al. Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med. 2009, 360(4):329-338.
27. Castro-Rodriguez J.A., Holberg C.J., Wright A.L., Martinez F.D. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000, 162(4 Pt 1):1403-1406.
28. Matricardi P.M., Illi S., Gruber C., Keil T., Nickel R., Wahn U., et al. Wheezing in childhood: incidence, longitudinal patterns and factors predicting persistence. Eur Respir J. 2008, 32(3):585-592.
29. Ducharme F.M., Lemire C., Noya F.J., Davis G.M., Alos N., Leblond H., et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med. 2009, 360(4):339-353.
30. Petsky H.L., Cates C.J., Li A.M., Kynaston J.A., Turner C., Chang A.B. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev. 2008, 2:CD006340.
31. Szefler S.J., Mitchell H., Sorkness C.A., Gergen P.J., O'Connor G.T., Morgan W.J., et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet. 2008, 372(9643):1065-1072.
32. de Jongste J.C., Carraro S., Hop W.C., Baraldi E. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med. 2009, 179(2):93-97.
33. Pijnenburg M.W., Bakker E.M., Hop W.C., De Jongste J.C. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med. 2005, 172(7):831-836.
34. Fritsch M., Uxa S., Horak F., Putschoegl B., Dehlink E., Szepfalusi Z., et al. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol. 2006, 41(9):855-862.
35. Braunholtz D.A., Edwards S.J., Lilford R.J. Are randomized clinical trials good for us (in the short term)? Evidence for a " trial effect" J Clin Epidemiol. 2001, 54(3):217-224.
36. Strunk R.C., Bacharier L.B., Phillips B.R., Szefler S.J., Zeiger R.S., Chinchilli V.M., et al. Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J Allergy Clin Immunol. 2008, 122(6). 1138-1144 e4.
37. Haldar P., Pavord I.D., Shaw D.E., Berry M.A., Thomas M., Brightling C.E., et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008, 178(3):218-224.